ENYO Pharma
Business Description ENYO Pharma is a clinical-stage firm with a unique virus-inspired approach. With many applications, our biotech mimics virus technique to alter host cellular activities.
Infectious disorders (e.g. HBV), metabolic diseases (e.g. NASH), and oncology are among the indications in which we investigate new therapeutic candidates.
Vonafexor (EYP001, FXR agonist), our lead candidate, is in Phase 2 for chronic hepatitis B and non-alcoholic steato-hepatitis. EYP002, our second candidate, is currently undergoing preclinical testing. It was originally created to combat the influenza virus, but because it has a mitochondrial cellular target, ENYO Pharma is looking into other indications such as oncology and metabolic illnesses.
Tags Biopharma, Biotechnology, Medical
Website http://www.enyopharma.com/
Articles about ENYO Pharma:
💡 You're a corporate or investor and looking for startups that are innovating in the same market as
ENYO Pharma? We're happy to assist you with our
Startup Sourcing service.